An observational study in Hypotension on Induction, Cardiac Surgery and Antihypertensive Agents, sponsored by Konya City Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Konya City Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Hypotension with a site in Turkey — 34 open to participants now, 35 under way, none of them phase 3. Hypotension · Turkey.
Among the 96 studies in Hypotension with a site in Turkey, this one is the 24th largest by enrollment of the 62 observational ones that give a count, is one of 24 that started in 2026, is one of 62 observational ones, and was the 73rd registered.
892 studies on the registry are indexed under Hypotension; 199 are open to participants now.
Browse Hypotension studies →34 of the 96 studies in Hypotension with a site in Turkey are open now. Recruiting first, the newest first:
Kayseri City Hospital · Sites in Turkey
Ages 18+ · Women only
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Sites in Turkey
Ages 18+
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Ordu University · Sites in Turkey
Ages 18–40 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 40 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 24 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 103 is above the median of 93 across 269 observational studies indexed under Hypotension.
Median enrollment 101 across the 34 interventional studies, 100 across the 62 observational. Of the 53 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 96 has an industry lead sponsor. The 10 most frequent:
Konya City Hospital is the lead sponsor of 82 studies on the registry; 24 are open to participants now.
Konya City Hospital has 4 studies filed under Hypotension — fewer than ten, so there is no comparison to draw.
17 of the studies in Hypotension with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07794852Istanbul UniversityDural Sac Area-Guided Spinal Anesthesia Dosing for TURP | 2026-11-24 |
| NCT05993481Konya City HospitalThe Noninvasive Blood Pressure Measurement Effect on the Hypotension | 2026-11-25 |
| NCT07539896Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalThe Role of Preoperative Internal Jugular Vein Collapsibility and Perfusion Index in Predicting Hypotension After Spinal Anesthesia in Elective Cesarean Sections: A Prospective Observational Study | 2026-11-25 |
| NCT05960604Recep Tayyip Erdogan UniversityPressure Recording Analytical Method Parameters and Their Relationship With Hypotension in Hypertensive Patients | 2026-12 |
| NCT07777159Ankara City Hospital BilkentCarotid Doppler Changes After Passive Leg Raising for Prediction of Post-Induction Hypotension in Gastrointestinal Tumor Surgery | 2026-12 |
Add all 17 to your calendar (.ics) → With an account.
Among the 96 studies in Hypotension with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to investigate the impact of multiple preoperative antihyperstensive drug use on the burden of post-induction hypotension (PIH) in patients undergoing elective cardiac surgery. The researchers will observe whether the combination of different antihypertensive classes (such as ACE inhibitors, ARBs, beta-blockers, and calcium channel blockers) leads to a higher incidence and severity of blood pressure drops and increased need for vasoactive support during the period between anesthesia induction and surgical incision.
Post-induction hypotension (PIH) is a critical period in cardiac anesthesia that can lead to organ hypoperfusion. This prospective observational study will include patients aged 18-85 with ASA III-IV physical status scheduled for elective cardiac surgery.
Preoperatively, patients' chronic antihypertensive medications will be recorded and categorized. Following standard anesthesia induction, hemodynamic parameters will be monitored using invasive arterial blood pressure measurement. PIH burden will be defined as the area under the curve (AUC) for a mean arterial pressure (MAP) lower than 65 mmHg. Additionally, the study will record the total dose of ephedrine or other vasoactive agents required to maintain hemodynamic stability. The primary goal is to determine if multiple antihypertensive therapy is an independent risk factor for increased PIH burden and to compare the effects of different drug combinations on early intraoperative hemodynamics.
Adult patients (40 years and older) who are scheduled for elective cardiac surgery under general anesthesia at a single tertiary center and have been on a stable regimen of one or more antihypertensive medications for at least one month preoperatively.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adult patients aged 18 to 85 years with ASA physical status III-IV, who are scheduled to undergo elective cardiac surgery under general anesthesia.
Other: Chronic Antihypertensive Medication Use
Patients' chronic antihypertensive drug use (number of drugs and pharmacological classes) will be recorded. This is an observational study where existing medication regimens (ACE inhibitors, ARBs, Beta-blockers, Calcium Channel Blockers, Diuretics) are documented to analyze their impact on the post-induction hypotension burden (MAP \< 55 mmHg).
Also known as: Multiple Antihypertensive Therapy
Post-induction Hypotension (PIH) Burden
The hypotension burden is defined as the area under the threshold (AUT) for a mean arterial pressure (MAP) \<55 mmHg. It is calculated using the formula: AUT\<55 = ∫(55 - MAP(t))dt for all values where MAP is below 55 mmHg. This measure integrates both the severity and duration of hypotension.
Time frame: From the start of anesthesia induction until 15 minutes post-induction or until central venous catheter placement, whichever occurs first.
Total Vasopressor Dose
The total amount of vasopressors (e.g., ephedrine, norepinephrine) administered to treat post-induction hypotension.
Time frame: From the start of anesthesia induction until 15 minutes post-induction.
Incidence of Post-induction Hypotension
Percentage of patients experiencing at least one episode of MAP \<55 mmHg.
Time frame: From the start of anesthesia induction until 15 minutes post-induction.
Plan to share: No — De-identified individual participant data underlying the results reported in this article will be available after publication to researchers who provide a methodologically sound proposal.
Ran from May 2026 to primary completion in Oct 2026, 5 months.
Of 149 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's 5 months is below that.
Counting every sponsor, half of 154 studies reached it within 11 months; a quarter within 5 and three quarters within 25.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: primary completion Nov 2026 → Oct 2026 and completion Dec 2026 → Oct 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Konya City Hospital